Tricol Biomedical, a privately held medical device company dedicated to saving lives through innovative hemostatic and wound care solutions, today announced an exclusive distribution agreement for the Tricol Biomedical family of hemostatic products with Medline Industries, a healthcare company doing business in more than 90 countries worldwide. Innovative hemostatic products, such as Tricol’s ChitoPulse radial band, are being introduced as part of the Tricol-Medline exclusive agreement.
Tricol Biomedical, a privately held medical device company dedicated to saving lives through innovative hemostatic and wound care solutions, today announced an exclusive distribution agreement for the Tricol Biomedical family of hemostatic products with Medline Industries, a healthcare company doing business in more than 90 countries worldwide. Innovative hemostatic products, such as Tricol’s ChitoPulse radial band, are being introduced as part of the Tricol-Medline exclusive agreement.